The largest conference for the BioPharma Competitive Intelligence Community is heading back to Europe! The only place to get the best information concerning healthcare, pharmaceuticals, biotechnology, and medical devices is at the Pharma CI Europe Conference on February 19-20, 2013 in Zurich, Switzerland . The overwhelming success of the 2012 event has everyone in the industry clamoring for another high-quality event.
“The Pharma CI Europe 2012 Conference was an extremely well-organised event and the best Pharma CI conference I have attended. There was a perfect balance of CI professionals from industry and agency representatives from CI service providers. It provided a great forum to network, share insights and learn from one another. I look forward to next year’s conference and will highly recommend the event to colleagues,” said a participant from Johnson & Johnson.
More than 150 participants came in February 2012 and they were wowed by the impressive speaking faculty of expert speakers from prestigious companies like Actelion, Amgen, Bausch + Lomb, Chiesi Farmaceutici, DSM, F. Hoffmann-La Roche, GlaxoSmithKline, Helsinn Healthcare, Johnson & Johnson, MedImmune, Merck, Novartis, Nycomed, Onyx, Pfizer, Sanofi-Aventis, Shire, Takeda, Virbac, and many more!
“The EUR CI in Pharma conference was a valuable professional experience in terms of pharma-specific CI content, networking and best practice. I would highly recommend this event to anyone involved in the competitive intelligence field in the healthcare arena,” said a participant from Takeda.
The Pharma CI Conference is THE INDUSTRY'S GOLD STANDARD for senior level pharmaceutical, biotechnology, medical device, and diagnostics professionals seeking the latest news and the industry’s best networking opportunities.
“The Pharma CI conference in Zurich was an outstanding meeting to interact with colleagues and experts globally. The forum provides a great opportunity to learn about key developments in our industry, to challenge ideas, share best practices and to network. I am really looking forward to join again next year and can highly recommend this conference,” said a participant from Novartis.